Stopped: patients enrolled got vaccinated vs COVID-19 and Influenza
Scarce information exists in relation to the effect of supplementation of Vitamin D3 in SARS-COV-2 infection, H1N1, and A, B Influenza when 25-hydroxyvitamin levels are between 20-100ng/ml. This study will evaluate the effect of supplementation of vitamin D3 vs. dietary-hygiene measures in SARS-COV-2 , H1N1, A, B Influenza infection rate in patients with serum 25-hydroxyvitamin D3 levels \>20ng/ml. A comparative randomized study that will evaluate the effect of a monthly supplementation with 52000 units of Vitamine D3 during three months vs hygienic-dietary measures in the development of respiratory infections such as COVID-19, H1N1, A, B Influenza during 6 months of follow-up in health workers from a hospital in Northern Mexico with serum vitamin D values +/- 20ng/ml. Also, patients that during screening have 25-hydroxyvitamin D3 levels \<20 ng/ml will receive vitamin D supplementation according to primary care discretion for three months and will be followed for 6 months and infection rate will be analyzed and compared.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Number of participants with Covid-19 Infection with Vitamin D3 > 20ng/ml
Timeframe: 6 months
Number of participants with Influenza H1N1 infection with Vitamin D3 > 20ng/ml
Timeframe: 6 months
Number of participants with Influenza A infection with Vitamin D3 > 20ng/ml
Timeframe: 6 months
Number of participants with Influenza B infection with Vitamin D3 > 20ng/ml
Timeframe: 6 months